Article
Inhibitory effects of cytoskeleton disrupting drugs and GDP-locked Rab mutants on bradykinin B₂ receptor cycling.
Pharmacological research - 1 May 2013
Charest-Morin Xavier, Fortin Sébastien, Lodge Robert, Roy Caroline, Gera Lajos, Gaudreault René C, Marceau François
Abstract excerpt
The bradykinin (BK) B₂ receptor (B₂R) is G protein coupled and phosphorylated upon agonist stimulation; its endocytosis and recycling are documented. We assessed the effect of drugs that affect the cytoskeleton on B2R cycling. These drugs were targeted to tubulin (paclitaxel, or the novel combret...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
